DS
BEAM icon

DRW Securities’s Beam Therapeutics BEAM Stock Holding History

DRW Securities’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$214K Buy
+8,997
New +$250K ﹤0.01% 1072
2025
Q3 		– Sell
-13,896
Closed -$236K – 1297
2025
Q2 		$236K Buy
+13,896
New +$242K 0.01% 862

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

DRW Securities's BEAM Position: Q1 2026 in Review

DRW Securities opened a new position in Beam Therapeutics (BEAM) in Q1 2026: 8,997 shares worth $214K. The stake represents ﹤0.01% of the portfolio and ranks #1072 among its holdings. This is a return to the name: DRW Securities previously reported a position in BEAM as recently as Q2 2025.

DRW Securities first reported a position in BEAM in Q2 2025 and has held it in 2 quarters since. The position peaked at $236K in Q2 2025. 252 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • DRW Securities held 8,997 shares of Beam Therapeutics worth $214K as of Q1 2026.
  • Beam Therapeutics was a new DRW Securities position in Q1 2026.
  • Beam Therapeutics made up ﹤0.01% of DRW Securities's portfolio in Q1 2026, its #1072 holding.
  • DRW Securities first reported a position in Beam Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • DRW Securities's Beam Therapeutics position peaked at $236K in Q2 2025.
  • 252 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.